Ouro Medicines is a biotechnology company developing immune reset therapeutics for chronic immune-mediated diseases, with a focus on B cell biology and T cell engagers.

Sitryx Therapeutics is a biopharmaceutical company that develops disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by targeting and regulating cell metabolism.